Advances in Clinical and Experimental Medicine

Title abbreviation: Adv Clin Exp Med
JCR Impact Factor (IF) – 2.1 (5-Year IF – 2.0)
Journal Citation Indicator (JCI) (2023) – 0.4
Scopus CiteScore – 3.7 (CiteScore Tracker 3.8)
Index Copernicus  – 171.00; MNiSW – 70 pts

ISSN 1899–5276 (print)
ISSN 2451-2680 (online)
Periodicity – monthly

Download original text (EN)

Advances in Clinical and Experimental Medicine

2020, vol. 29, nr 9, September, p. 1123–1129

doi: 10.17219/acem/125433

Publication type: review

Language: English

License: Creative Commons Attribution 3.0 Unported (CC BY 3.0)

Download citation:

  • BIBTEX (JabRef, Mendeley)
  • RIS (Papers, Reference Manager, RefWorks, Zotero)

Advances in ultrasound-guided thermal ablation for symptomatic benign thyroid nodules

Zhigang Cheng1,B,D,E, Ping Liang1,A,C,F

1 Department of Interventional Ultrasound, Chinese People’s Liberation Army General Hospital, Beijing, China

Abstract

Benign thyroid nodules (BTNs), which account for 85–95% of all thyroid nodules (TNs), are a common clinical issue and have been increasingly detected over the last 2 decades due to the widespread use of ultrasound (US) imaging. The clinical treatment for BTNs is mainly focused on patients with nodular growth or clinical problems, either cosmetic or symptom-related. Percutaneous thermal ablation (TA) under US guidance has increasingly become a satisfactorily minimally invasive alternative to surgery for patients with symptomatic BTNs, especially for those in nonsurgical candidates, surgically high-risk individuals or patients refusing surgery. Based on the available English-language literature, the brief principles, procedures and clinical outcomes of 4 TA techniques, including laser ablation therapy (LAT), radiofrequency ablation (RFA), microwave ablation (MWA), and high-intensity focused ultrasound (HIFU) in the treatment of BTNs were retrospectively reviewed in this article. Good curative efficacy and clinical safety were noted in the published reports of the 4 TA techniques in the treatment of BTNs, with nodular volume reduction ratios of 46–93.5%, significant improvement in symptomatic and cosmetic problems, and euthyroid preservation for most patients. The conclusion is that all 4 TA techniques can be safe and effective treatment for patients with symptomatic BTNs; RFA seems to be the best because of the highest nodular volume reduction ratio (VRR) at follow-up. Furthermore, the image fusion navigation technique will play an important role through assisting in precise ablation for BTNs.

Key words

ultrasonography, thyroid nodule, ablation

References (49)

  1. Russ G, Leboulleux S, Leenhardt L, Hegedüs L. Thyroid incidentalomas: Epidemiology, risk stratification with ultrasound and workup. Eur Thyroid J. 2014;3(3):154–163.
  2. Gharib H, Papini E, Paschke R, et al; AACE/AME/ETA Task Force on Thyroid Nodules. American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and European Thyroid Association medical guidelines for clinical practice for the diagnosis and management of thyroid nodules: Executive summary of recommendations. J Endocrinol Invest. 2010;33(5 Suppl):51–56.
  3. Ha EJ, Baek JH. Advances in nonsurgical treatment of benign thyroid nodules. Future Oncol. 2014;10(8):1399–1405.
  4. Durante C, Costante G, Lucisano G, et al. The natural history of benign thyroid nodules. JAMA. 2015;313(9):926–935.
  5. Mullur R, Liu YY, Brent GA. Thyroid hormone regulation of metabolism. Physiol Rev. 2014;94(2):355–382.
  6. Choi SH, Kim EK, Kim SJ, Kwak JY. Thyroid ultrasonography: Pitfalls and techniques. Korean J Radiol. 2014;15(2):267–276.
  7. Gharib H, Hegedüs L, Pacella CM, Baek JH, Papini E. Clinical review: Nonsurgical, image-guided, minimally invasive therapy for thyroid nodules. J Clin Endocrinol Metab. 2013;98(10):3949–3957.
  8. Papini E, Pacella CM, Hegedus L. Diagnosis of endocrine disease. Thyroid ultrasound (US) and US-assisted procedures: From the shadows into an array of applications. Eur J Endocrinol. 2014;170(4):R133–R146.
  9. Jeong WK, Baek JH, Rhim H, et al. Radiofrequency ablation of benign thyroid nodules: Safety and imaging follow-up in 236 patients. Eur Radiol. 2008;18(6):1244–1250.
  10. Lim HK, Lee JH, Ha EJ, Sung JY, Kim JK, Baek JH. Radiofrequency ablation of benign non-functioning thyroid nodules: 4-year follow-up results for 111 patients. Eur Radiol. 2013;23(4):1044–1049.
  11. Deandrea M, Limone P, Basso E, et al. US-guided percutaneous radiofrequency thermal ablation for the treatment of solid benign hyperfunctioning or compressive thyroid nodules. Ultrasound Med Biol. 2008;34(5):784–791.
  12. Papini E, Guglielmi R, Bizzarri G, Pacella CM. Ultrasound-guided laser thermal ablation for treatment of benign thyroid nodules. Endocr Pract. 2004;10(3):276–283.
  13. Valcavi R, Riganti F, Bertani A, Formisano D, Pacella CM. Percutaneous laser ablation of cold benign thyroid nodules: A 3-year follow-up study in 122 patients. Thyroid. 2010;20(11):1253–1261.
  14. Døssing H, Bennedbæk FN, Hegedüs L. Long-term outcome following interstitial laser photocoagulation of benign cold thyroid nodules. Eur J Endocrinol. 2011;165(1):123–128.
  15. Feng B, Liang P, Cheng Z, et al. Ultrasound-guided percutaneous microwave ablation of benign thyroid nodules: Experimental and clinical studies. Eur J Endocrinol. 2012;166(6):1031–1037.
  16. Yue W, Wang S, Wang B, et al. Ultrasound guided percutaneous microwave ablation of benign thyroid nodules: Safety and imaging follow-up in 222 patients. Eur J Radiol. 2013;82(1):e11–e16.
  17. Kovatcheva RD, Vlahov JD, Stoinov JI, Zaletel K. Benign solid thyroid nodules. US-guided high-intensity focused ultrasound ablation: Initial clinical outcomes. Radiology. 2015;276(2):597–605.
  18. Korkusuz H, Fehre N, Sennert M, Happel C, Grünwald F. Volume reduction of benign thyroid nodules 3 months after a single treatment with high-intensity focused ultrasound (HIFU). J Ther Ultrasound. 2015;3:4.
  19. Baek JH, Lee JH, Sung JY, et al. Complications encountered in the treatment of benign thyroid nodules with US-guided radiofrequency ablation: A multicenter study. Radiology. 2012;262(1):335–342.
  20. Ha EJ, Baek JH, Lee JH, et al. Radiofrequency ablation of benign thyroid nodules does not affect thyroid function in patients with previous lobectomy. Thyroid. 2013;23(3):289–293.
  21. Ji Hong M, Baek JH, Choi YJ, et al. Radiofrequency ablation is a thyroid function-preserving treatment for patients with bilateral benign thyroid nodules. J Vasc Interv Radiol. 2015;26(1):55–61.
  22. Masters A, Steger AC, Lees WR, Walmsley KM, Bown SG. Interstitial laser hyperthermia: A new approach for treating liver metastases. Br J Cancer. 1992;66(3):518–522.
  23. Skinner MG, Iizuka MN, Kolios MC, Sherar MD. A theoretical comparison of energy sources: Microwave, ultrasound and laser for interstitial thermal therapy. Phys Med Biol. 1998;43(12):3535–3547.
  24. Pacella CM, Bizzarri G, Guglielmi R, et al. Thyroid tissue. US-guided percutaneous interstitial laser ablation: A feasibility study. Radiology. 2000;217(3):673–677.
  25. Døssing H, Bennedbaek FN, Karstrup S, Hegedüs L. Benign solitary solid cold thyroid nodules. US-guided interstitial laser photocoagulation: Initial experience. Radiology. 2002;225(1):53–57.
  26. Papini E, Rago T, Gambelunghe G, et al. Long-term efficacy of ultrasound-guided laser ablation for benign solid thyroid nodules: Results of a three-year multicenter prospective randomized trial. J Clin Endocrinol Metab. 2014;99(10):3653–3659.
  27. Di Rienzo G, Surrente C, Lopez C, Quercia R. Tracheal laceration after laser ablation of nodular goitre. Interact Cardiovasc Thorac Surg. 2012;14(1):115–116.
  28. Haemmerich D, Pilcher TA. Convective cooling affects cardiac catheter cryoablation and radiofrequency ablation in opposite directions. Conf Proc IEEE Eng Med Biol Soc. 2007;2007:1499–1502.
  29. Na DG, Lee JH, Jung SL, et al. Radiofrequency ablation of benign thyroid nodules and recurrent thyroid cancers: Consensus statement and recommendations. Korean J Radiol. 2012;13(2):117–125.
  30. Kim YS, Rhim H, Tae K, Park DW, Kim ST. Radiofrequency ablation of benign cold thyroid nodules: Initial clinical experience. Thyroid. 2006;16(4):361–367.
  31. Ahmed M, Brace CL, Lee FT Jr, Goldberg SN. Principles of and advances in percutaneous ablation. Radiology. 2011;258(2):351–369.
  32. Brace CL. Microwave ablation technology: What every user should know. Curr Probl Diagn Radiol. 2009;38(2):61–67.
  33. Liang P, Wang Y. Microwave ablation of hepatocellular carcinoma. Oncology. 2007;72(Suppl 1):124–131.
  34. Wang Y, Sun Y, Feng L, Gao Y, Ni X, Liang P. Internally cooled antenna for microwave ablation: Results in ex vivo and in vivo porcine livers. Eur J Radiol. 2008;67(2):357–361.
  35. Korkusuz H, Nimsdorf F, Happel C, Ackermann H, Grünwald F. Percutaneous microwave ablation of benign thyroid nodules: Functional imaging in comparison to nodular volume reduction at a 3-month follow-up. Nuklearmedizin. 2015;54(1):13–19.
  36. Malietzis G, Monzon L, Hand J, et al. High-intensity focused ultrasound: Advances in technology and experimental trials support enhanced utility of focused ultrasound surgery in oncology. Br J Radiol. 2013;86(1024):20130044.
  37. Jenne JW, Preusser T, Günther M. High-intensity focused ultrasound: Principles, therapy guidance, simulations and applications. Z Med Phys. 2012;22(4):311–322.
  38. Esnault O, Rouxel A, Le Nestour E, Gheron G, Leenhardt L. Minimally invasive ablation of a toxic thyroid nodule by high-intensity focused ultrasound. AJNR Am J Neuroradiol. 2010;31(10):1967–1968.
  39. Esnault O, Franc B, Ménégaux F, et al. High-intensity focused ultrasound ablation of thyroid nodules: First human feasibility study. Thyroid. 2011;21(9):965–973.
  40. Ha EJ, Baek JH, Kim KW, et al. Comparative efficacy of radiofrequency and laser ablation for the treatment of benign thyroid nodules: Systematic review including traditional pooling and Bayesian network meta-analysis. J Clin Endocrinol Metab. 2015;100(5):1903–1911.
  41. Baek JH, Lee JH, Valcavi R, Pacella CM, Rhim H, Na DG. Thermal ablation for benign thyroid nodules: Radiofrequency and laser. Korean J Radiol. 2011;12(5):525–540.
  42. Cheng Z, Che Y, Yu S, et al. US-guided percutaneous radiofrequency versus microwave ablation for benign thyroid nodules: A prospective multicenter study. Sci Rep. 2017;7(1):9554.
  43. Esnault O, Franc B, Monteil JP, Chapelon JY. High-intensity focused ultrasound for localized thyroid-tissue ablation: Preliminary experimental animal study. Thyroid. 2004;14(12):1072–1076.
  44. Bernardi S, Dobrinja C, Fabris B, et al. Radiofrequency ablation compared to surgery for the treatment of benign thyroid nodules. Int J Endocrinol. 2014;2014:934595.
  45. Che Y, Jin S, Shi C, et al. Treatment of benign thyroid nodules: Comparison of surgery with radiofrequency ablation. AJNR Am J Neuroradiol. 2015;36(7):1321–1325.
  46. Turtulici G, Orlandi D, Corazza A, et al. Percutaneous radiofrequency ablation of benign thyroid nodules assisted by a virtual needle tracking system. Ultrasound Med Biol. 2014;40(7):1447–1452.
  47. Mauri G, Solbiati L. Virtual navigation and fusion imaging in percutaneous ablations in the neck. Ultrasound Med Biol. 2015;41(3):898.
  48. Orlandi D, Turtulici G. Reply regarding virtual navigation and fusion imaging in percutaneous ablations in the neck. Ultrasound Med Biol. 2015;41(3):899.
  49. Maybody M, Stevenson C, Solomon SB. Overview of navigation systems in image-guided interventions. Tech Vasc Interv Radiol. 2013;16(3):136–143.
© Wroclaw Medical University